Both in Biotechnology
Atara Biotherapeutics vs Neumora Therapeutics
Over the past year ATRA returned −37.8% and NMRA returned −79.6%; their daily moves had a correlation of 0.03.
ATRA −37.8% NMRA −79.6%Growth of $1, one year, split-adjusted
| Metric | ATRA | NMRA |
|---|---|---|
| Price | $8.62 | $0.6148 |
| Market cap | $86.5M | $115.5M |
| Today | +1.65% | +24.03% |
| 1 month | −8.3% | +17.0% |
| 6 months | +81.1% | −73.3% |
| Year to date | −52.3% | −65.7% |
| 1 year | −42.0% | −79.6% |
| Revenue growth (YoY) | −96.4% | — |
| Gross margin | 69.7% | — |
| Net margin | −767.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 14.0× | — |
| Net cash | $9.9M | $63.9M |
| Dividend yield | — | — |
| Volatility (60d) | 65.2% | 131.0% |
| Short % of float | 11.2% | 6.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).